Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
Ethical and epidemiological dimensions of labeling psychosis risk
Cheryl M. Corcoran
Research output
:
Contribution to journal
›
Article
›
peer-review
28
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Ethical and epidemiological dimensions of labeling psychosis risk'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Clinical High Risk for Psychosis (CHR-P)
100%
Schizophrenia
16%
First-episode Psychosis
16%
Prodromal Stage
16%
Predictive Power
16%
Ethical Issues
16%
Individualized Prediction
16%
Potential Harm
16%
Withholding
16%
Young People
16%
DSM-5
16%
Stigmatized
16%
Attenuated Psychotic Symptoms
16%
Public Health Education
16%
Reducing Stigma
16%
Paternalism
16%
Pharmacology, Toxicology and Pharmaceutical Science
Syndrome
100%
DSM-5
100%